Terms: = Kidney tumors AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Prognosis
4 results:
1.
Li N; Chu J; Hu K; Zhang H; Li N; Chu JF; Hu KY; Zhang HY
J Biosci; 2023; 48():. PubMed ID: 37309171
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma.
Kang Z; Yang J
J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019
[TBL] [Abstract] [Full Text] [Related]
3. Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.
Liu Y; Shang D
Mol Cell Biochem; 2020 Feb; 465(1-2):165-174. PubMed ID: 31848806
[TBL] [Abstract] [Full Text] [Related]
4. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
[TBL] [Abstract] [Full Text] [Related]
